5 Key Takeaways

• 1

  Higher cumulative dosages of isotretinoin are linked to reduced rates of acne relapse and treatment retrial in a study of 19,907 patients.

• 2

  22.5% of participants experienced acne relapse requiring systemic treatment, while 8.2% needed isotretinoin retrial.

• 3

  Female patients were more likely to experience relapse but less likely to undergo retrial treatment compared to male patients.

• 4

  The study found that higher cumulative dosage effects were primarily observed in patients receiving low and conventional doses.

• 5

  The absence of patient weight data in the MarketScan database limited the study, relying on national averages for calculations.